Elsevier Launches Program to Educate Young Researchers about the Importance of Research Integrity
AMSTERDAM, September 7, 2012 /PRNewswire/ –
A series of online training materials and interactive tools at
http://www.ethics.elsevier.com provides information on ethical boundaries and how to
avoid violations including research fraud, plagiarism, and duplicate submissions.
Elsevier [http://www.elsevier.com/wps/find/homepage.cws_home ], a world-leading
provider of scientific, technical and medical information products and services, today
announced the launch of a new Ethics in Research & Publication
[http://www.ethics.elsevier.com ] program, an initiative designed to help educate early
career researchers on the importance of research integrity.
The Ethics in Research & Publication program has come about through a collaboration
between Elsevier and an advisory panel of experts recognized for their deep understanding
of current ethical issues surrounding research and publishing and the evolving approaches
to solving them.
Distinguished panel members include Dr. David Rew, Medical Chair SCOPUS Content
Selection and Advisory Board; Prof. Alexander T (Sandy) Florence, Editor in Chief,
International Journal of Pharmaceutics; Ole G. Evensen Assistant Director, University of
Bergen Library, Norway; and Prof. Margaret Rees, Secretary of the Committee on Publication
“Research integrity should be put into the culture at all levels and educating young
researchers is a significant advance,” commented Prof. Rees.
The program is inspired by real-world stories of researchers who have been the victims
of misconduct. Researchers like Mary Kate Donais, Associate Professor of St. Anselm
College in Manchester, New Hampshire, who was once asked to review a manuscript and
noticed the introductory paragraph was taken from her own grant proposal. “I wonder if
that researcher was under pressure and decided to cut corners without thinking about the
ethics behind it,” said Donais.
With the goal of addressing the growing incidence of publishing ethics issues, the
program emphasizes the individual researcher’s contribution to advancing science through
integrity and good ethical standards. At the same time the program also highlights the
devastating impact misconduct can have on the science community as a whole, as well as on
an individual researcher’s career.
“Ethical issues are a shared problem for all involved in research and publishing. With
the Ethics in Research & Publication program, Elsevier tries to play its part in
addressing the problem by teaching young researchers the rules and how to comply with
them,” said Catriona Fennell, Director of Publishing Services, STM Journals at Elsevier.
“Our existing services have focused on detection and resolution of ethical issues, while
this new program focuses on preventing issues arising in the first place.”
For more information, go to: http://www.ethics.elsevier.com.
Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], ClinicalKey
[http://www.clinicalkey.com ] and Mosby’s Nursing Suite [http://www.confidenceconnected.com
], which enhance the productivity of science and health professionals, and the SciVal
suite [http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which
help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media contact Tom Reller Vice President, Global Corporate Relations, Elsevier +1-215-239-3508 email@example.com